Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 55, 2020 - Issue 10
Submit an article Journal homepage
4,308
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)

S. Vatna Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6124-4995View further author information
ORCID Icon,
A. Carstensc Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden;d Department of Internal Medicine, Ersta Hospital, Stockholm, SwedenView further author information
,
A. B. Kristoffersene Genetic Analysis AS, Oslo, NorwayView further author information
,
D. Bergemalmc Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, SwedenView further author information
,
C. Caséne Genetic Analysis AS, Oslo, NorwayORCID Iconhttps://orcid.org/0000-0002-7632-8251View further author information
ORCID Icon,
A. E. F. Moenb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;f Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, NorwayView further author information
,
T. M. Tannaesb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;f Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, NorwayView further author information
,
J. Lindstrømb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;g Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway;h Department of Pediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, NorwayView further author information
,
T. E. Detliea Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayORCID Iconhttps://orcid.org/0000-0002-1576-5298View further author information
ORCID Icon,
C. Olbjørnb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;i Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, SwedenView further author information
,
C. M. Lindquistc Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, SwedenView further author information
,
J. D. Söderholmj Digestive Diseases Unit, IIS Aragón, Zaragoza, SpainView further author information
,
F. Gomollónk Gastrointestinal Unit, Centre for Genomics and Molecular Medicine, Division of Medical and Radiological Sciences, University of Edinburgh, Edinburgh, UKView further author information
,
R. Kallal Translational Gastroenterology Unit, Medical Sciences/Experimental Medicine Division, University of Oxford, Oxford, UKView further author information
,
J. Satsangil Translational Gastroenterology Unit, Medical Sciences/Experimental Medicine Division, University of Oxford, Oxford, UKView further author information
,
M. H. Vatnb Institute of Clinical Medicine, University of Oslo, Oslo, NorwayView further author information
,
J. Jahnsena Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayORCID Iconhttps://orcid.org/0000-0002-0419-2914View further author information
ORCID Icon,
J. Halfvarsonc Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, SwedenView further author information
,
P. Ricaneka Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, NorwayView further author information
& the IBD-Character Consortium show all
Pages 1146-1156 | Received 22 May 2020, Accepted 18 Jul 2020, Published online: 11 Aug 2020

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Susanna Meade, Jeremy Liu Chen Kiow, Cristian Massaro, Gurpreet Kaur, Elizabeth Squirell, Brian Bressler & Genelle Lunken. (2023) Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review. Gut Microbes 15:2.
Read now
Jan K. Nowak, Rahul Kalla & Jack Satsangi. (2023) Current and emerging biomarkers for ulcerative colitis. Expert Review of Molecular Diagnostics 23:12, pages 1107-1119.
Read now
Federica Giachero, Andreas Jenke & Matthias Zilbauer. (2021) Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. Expert Review of Clinical Immunology 17:8, pages 871-881.
Read now

Articles from other publishers (17)

Mukta Gupta, Bhupinder Kapoor & Monica Gulati. (2024) Bacterial consortia-The latest arsenal to inflammatory bowel disease bacteriotherapy. Medicine in Microecology 20, pages 100107.
Crossref
Chen Wang, Yu Gu, Qiao Chu, Xin Wang, Yiyun Ding, Xiali Qin, Tianyu Liu, Sinan Wang, Xiang Liu, Bangmao Wang & Hailong Cao. (2024) Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review. Microbiological Research 282, pages 127660.
Crossref
Laura Arosa, Miguel Camba-Gómez, Olga Golubnitschaja & Javier Conde-Aranda. (2024) Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations. EPMA Journal 15:1, pages 111-123.
Crossref
Leilei Jiang, Xiaoming Liu, Yue Su, Yujie Chen, Shaozhi Yang, Xiquan Ke, Kunhou Yao & Zhiguo Guo. (2024) A metabolomics-driven model for early remission prediction following vedolizumab treatment in patients with moderate-to-severe active ulcerative colitis. International Immunopharmacology 128, pages 111527.
Crossref
Rongrong Wu, Rui Xiong, Yan Li, Junru Chen & Ru Yan. (2023) Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation. Journal of Autoimmunity 141, pages 103062.
Crossref
Garima Juyal, Ajit Sood, Vandana Midha, Arshdeep Singh, Dharmatma Singh, Ramit Mahajan, Vijay Verma, Rakesh Bhatnagar & Mohan C. Joshi. (2023) Enrichment of Lactic Acid-Producing Bacteria in the Fecal Microbiota of Patients with Ulcerative Colitis in North India. Advanced Gut & Microbiome Research 2023, pages 1-14.
Crossref
Liang-Fang Wang, Ping-Run Chen, Si-Ke He, Shi-Hao Duan & Yan Zhang. (2023) Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review. World Journal of Gastroenterology 29:29, pages 4481-4498.
Crossref
Jie Liu, Huaying Fang, Na Hong, Chaolan Lv, Qihua Zhu, Yinping Feng, Bo Wang, Jiashuang Tian & Yue Yu. (2023) Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis. Microbiology Spectrum 11:3.
Crossref
Sudhir K. Yadav, Naoko Ito, John E. Mindur, Hetal Kumar, Mysra Youssef, Shradha Suresh, Ratuja Kulkarni, Yaritza Rosario, Konstantin E. Balashov, Suhayl Dhib-Jalbut & Kouichi Ito. (2022) Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis. Frontiers in Immunology 13.
Crossref
Ying Wang, Guojun Wu, Liping Zhao & Weizheng Wang. (2022) Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome. mBio 13:2.
Crossref
Burcu Bakir-Gungor, Hilal Hacılar, Amhar Jabeer, Ozkan Ufuk Nalbantoglu, Oya Aran & Malik Yousef. (2022) Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods. PeerJ 10, pages e13205.
Crossref
Natalia Molinero, Diego Taladrid, Irene Zorraquín-Peña, Miguel de Celis, Ignacio Belda, Alex Mira, Begoña Bartolomé & M. Victoria Moreno-Arribas. (2022) Ulcerative Colitis Seems to Imply Oral Microbiome Dysbiosis. Current Issues in Molecular Biology 44:4, pages 1513-1527.
Crossref
Shinya Fukushima, Akiko Shiotani, Hiroshi Matsumoto, Osamu Handa, Yukiko Handa, Motoyasu Osawa, Takahisa Murao, Eiji Umegaki, Mitsuoki Kawano, Ryo Inoue & Yuji Naito. (2022) Comparison of mucosa-associated microbiota in Crohn’s disease patients with and without anti-tumor necrosis factor-α therapy. Journal of Clinical Biochemistry and Nutrition 70:2, pages 182-188.
Crossref
Laila Aldars-García, María Chaparro & Javier P. Gisbert. (2021) Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease. Microorganisms 9:5, pages 977.
Crossref
Lena Öhman, Anders Lasson, Anna Strömbeck, Stefan Isaksson, Marcus Hesselmar, Magnus Simrén, Hans Strid & Maria K. Magnusson. (2021) Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis. Scientific Reports 11:1.
Crossref
Guanglin Cui, Qingbo Fan, Zhenfeng Li, Rasmus Goll & Jon Florholmen. (2021) Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. eBioMedicine 66, pages 103329.
Crossref
Petra Adamkova, Petra Hradicka, Sona Gancarcikova, Monika Kassayova, Lubos Ambro, Izabela Bertkova, Martin Maronek, Silvia Farkasova Iannaccone & Vlasta Demeckova. (2021) Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. Pathogens 10:2, pages 152.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.